Research + Education
Download Our Study
In March 2020, 40 diverse individuals from all walks of life embarked on a journey with us to complete a seven week comprehensive microdosing study. The goal was to prove the positive effects microdosing has on mental health and to show Canadians the importance of removing the stigma around psilocybin and move psychedelic therapies closer to legalization.
The findings of the study were incredibly promising. View the results of the study below;
Find out what's happening in the world of
First-of-its-kind study on psilocybin microdosing aims to establish whether the effects are as profound as people say they are.
In a double-blind, placebo-controlled experiment, neuroscientists carefully analyzed what happens to glutamate levels and a person’s ego when taking psilocybin, the active ingredient in magic mushrooms.
The federal government has supported finding new effective psychiatric treatments. The FDA has designated MDMA-assisted and psilocybin-assisted therapy as breakthrough therapies, a status granted when preliminary clinical evidence indicates that a drug may demonstrate substantial improvement over available therapies.
As Canadians head towards polls this September we are searching for leaders who will help us come through this long pandemic. Recently, Conservative leader Erin O’Toole declared that his party is eager to support all Cana- dians, including those from the LGBT community interested in consuming“poppers”.
Join us for this week’s episode of the Psychedelic Entrepreneur as Beth interviews attorney, Greg Lake, who specializes in establishing entheogenic churches and other legal issues related to psychedelic facilitation and use.
This week we received the disappointing news that California has delayed its impressive push to decriminalize psychedelics. Having made it through many levels of the legislature, the bill is now being shelved until next year, likely for political reasons as California’s governor is facing a surprise recall election.
This chart is not intended to be used to make medical decisions and is for informational purposes only. It was constructed using data whenever possible, although extrapolation from known information was also used to inform risk. Any decision to start, stop, or taper medication and/or use psychedelic drugs should be made in conjunction with your healthcare provider(s). It is recommended to not perform any illicit activity.
Curious about the purported beneficial effects of psilocybin mushrooms on the mind, the writer decided to attend a guided hallucinogenic trip. Attending a guided magic mushroom trip turned out to be the most important event in his life
Nagano, M., Shimizu, K., Kondo, R., Hayashi, C., Sato, D., Kitagawa, K., & Ohnuki, K. (2010)
Biomedical Research (Tokyo, Japan), 31(4)
Rossi, P., Buonocore, D., Altobelli, E., Brandalise, F., Cesaroni, V., Iozzi, D., Savino, E., Marzatico, F. (2014)
Evidence-Based Complementary and Alternative Medicine, Volume 2014
Eric W. Dolan, May 18, 2021
Emmanuelle A. D. Schindler, R. Andrew Sewell, Christopher H. Gottschalk, Christina Luddy, L. Taylor Flynn, Hayley Lindsey, Brian P. Pittman, Nicholas V. Cozzi, and Deepak C. D’Souza.
Jennifer Walker-Journey May 17, 2021
Researcher J.E.C. Anthony, Psychedelic Spotlight
From treating depression to understanding consciousness, the promise of psychedelics is shifting their study from fringe to frontier neuroscience.
In 2019 a small group of researchers at Imperial established the world’s first dedicated centre for
research into the action and clinical use of psychedelic compounds.
Ryan O’Hare 17 May 2021
Imperial College London
3 May 2021
THE NEW YORK TIME
Kyle Jaeger April 23, 2021
Jenna Romaine April 23, 2021
Madison Margolin & Shelby Hartman April 23, 2021
IBT Contributor On April 22, 2021
Alex Dorr Mar 24, 2021
Laura Gesualdi-Gilmore June 2nd, 2021
Kate Robertson on May 25, 2021
Jennifer Walker-Journey May 20, 2021
GOOD MORNING AMERICA
Kyle Jaeger 1st June 2021
Rory Carroll May 28, 2021
Natan Ponieman May 20, 2021
Tiffany Crawford Publishing date: Jun 01, 2021
Sarah Rose Siskind October 21, 2020
Jon Hernandez June 21, 2021
Cultivation Instructor June 16, 2021
Jennifer Walker-Journey June 25, 2021
DELILAH FRIEDLER 7th July 2021
CLAY SKIPPER July 7, 2021
Chloe Reichel/HLS Staff Contributor July 7, 2021
Harvard Law Today
A new clinical trial that will evaluate the effect of low doses of psilocybin in healthy, human volunteers will mark the third clinical psilocybin study that Canada has ever approved.
17th August 2021, Psychedelic Spotlight
Three mothers who microdose psilocybin told Insider it transformed them into more patient and present parents and helped with pregnancy and postpartum mental-health struggles.
INSIDER, 27th August 2021
Hopkins said in a statement that his album, which has no beats or drum sounds, grew from a 2018 expedition to Tayos Caves in Ecuador. “Music for Psychedelic Therapy is not ambient, classical or drone but has elements of all three,” he said. “For me it’s a place as much as it is a sound. It works for the sober mind, but takes on a new dimension entirely when brought into a psychedelic ceremony.”
Pitch Fork, SEP 2 2021
The paper also found theoretical matches between dysfunctional neural mechanisms and behavioral manifestations in ADHD and the subjective and neural effects of psychedelics. Microdosing these substances may even be safer and possibly more effective than both macrodosing them, and current ADHD medication.
Should a nursing parent abstain from psychedelics? Yes and no—here’s what the science and indigenous wisdom tell about this practice.
Double Blind Mag, 27th August 2021
Emma Seppälä, Christina Bradley, and Michael R. Goldstein
September 29, 2020
Harvard Business Review
May 21, 2020
UC San Diego News Center
Seren Hughes 6 May 2021
May 9, 2021
THE NEW YORK TIMES
The Center for Psychedelic and Consciousness Research at Johns Hopkins
Psychedelic Invest has compiled a list of the top 100 most influential people in
the psychedelics ecosystem. This list is focused on those who have had the
largest impact for 2021.
2 May 2021
Jake Romphf Apr. 14, 2021
COMOX VALLEY RECORD
Barbara E. Bauer April 14, 2021
PSYCHEDELIC SCIENCE REVIEW
Kaitlin Sullivan April 15, 2021
Eric W. Dolan March 29, 2021
Agustin Lugo-Radillo and Jorge Luis Cortes-Lopez.
Robin L Carhart-Harris, Leor Roseman, Mark Bolstridge, Lysia Demetriou, J Nienke Pannekoek, Matthew B Wall, Mark Tanner, Mendel Kaelen, John McGonigle, Kevin Murphy, Robert Leech, H Valerie Curran & David J Nutt. 13 October 2017
Psychedelic Research Group, Psychopharmacology Unit, Centre for Psychiatry, Department of Medicine, Imperial College London, W12 0NN, London, UK
Ian Sample 19 May 2021
Abigail E. Calder, MSc May 10, 2021
PSYCHEDELIC SCIENCE REVIEW
John Haltiwanger Jun 1, 2021
Buddy T Medically reviewed by Daniel B. Block, MD on January 29, 2020
VERY WELL MIND
The Canadian Press June 10, 2021
Robin Gill June 12 2021
Meryl Davids Landau Jun 10, 2021
GOOD HOUSE KEEPING
Andrea Germanos June 9, 2021
Shayla Love June 30, 2021
Curt Petrovich July 5, 2021
Grace Blest-Hopley Jun 1st 2021
Heroic Hearts UK
MELISSA LAVASANI Jun 10, 2021
MELISSA LAVASANI Jun 10, 2021
Dustin Marlan 1st March 2021